Health stories

WHO reveals Congo's fastest-growing Ebola outbreak began months before official declaration, as response teams struggle to contain spread

The World Health Organization disclosed that the Democratic Republic of Congo's Ebola outbreak, now the fastest-growing on record, actually started in February 2026—four months before its official declaration in mid-May. Health workers are racing to contain the virus that has spread at an alarming and unprecedented rate in eastern Congo.

Aug 10, 20266 sources

WHO reveals Congo's fastest-growing Ebola outbreak began months before official declaration, as response teams struggle to contain spread

MoonLake reports positive Phase 3 IZAR-1 results for sonelokimab in psoriatic arthritis

MoonLake Immunotherapeutics announced its experimental drug sonelokimab met all primary and secondary endpoints in the Phase 3 IZAR-1 trial for psoriatic arthritis in bio-naïve patients, achieving a 42.1% ACR50 response rate at Week 16. Despite the positive clinical results, the company's stock gapped down on Monday, opening at $17.24 after closing at $18.26.

Aug 10, 20264 sources

MoonLake reports positive Phase 3 IZAR-1 results for sonelokimab in psoriatic arthritis

Sionna Therapeutics halts cystic fibrosis drug development after trial failure

Sionna Therapeutics discontinued development of its experimental cystic fibrosis pill after it failed to show meaningful benefit when added to standard treatment in a mid-stage trial, causing shares to plunge.

Aug 10, 20262 sourcesDrug development Pharmaceutical Industry Clinical trials

Sionna Therapeutics halts cystic fibrosis drug development after trial failure

Novo Nordisk and Amazon Web Services Launch AI Co-Innovation Hub in London for Drug Discovery

Novo Nordisk and Amazon Web Services have formed a strategic partnership to accelerate drug discovery through artificial intelligence, establishing a new AI co-innovation hub in London that will bring together AWS engineers and AI specialists with Novo Nordisk's research and development teams.

Aug 10, 20263 sourcesAI for developers Business & enterprise AI

Novo Nordisk and Amazon Web Services Launch AI Co-Innovation Hub in London for Drug Discovery

FDA Moves to Close 'GRAS' Loophole Allowing Food Additives Without Federal Notification

The Trump administration announced a proposed rule requiring food companies to notify the FDA when introducing new additives under the 'generally recognized as safe' designation, closing a decades-old regulatory loophole that allowed manufacturers to self-certify ingredient safety without federal oversight.

Aug 10, 20268 sourcesFood additives Trump administration policy Public health

FDA Moves to Close 'GRAS' Loophole Allowing Food Additives Without Federal Notification

Jazz Pharmaceuticals to Acquire Actio Biosciences for Up to $1.32 Billion in Rare Epilepsy Deal

Jazz Pharmaceuticals announced a definitive agreement to acquire privately-held Actio Biosciences for $820 million upfront plus up to $500 million in milestone payments, gaining access to ABS-1230, an experimental treatment for KCNT1+ epilepsy, a rare inherited form of the disease with no approved therapies.

Aug 10, 20266 sources

Jazz Pharmaceuticals to Acquire Actio Biosciences for Up to $1.32 Billion in Rare Epilepsy Deal

Sobi and Innate Pharma Form $580M Partnership to Advance Lacutamab to Phase 3 for Rare Skin Cancer

Swedish Orphan Biovitrum (Sobi) and Innate Pharma announced a strategic partnership worth up to $580 million, with $75 million upfront, to advance lacutamab into the TELLOMAK-3 Phase 3 confirmatory trial for cutaneous T-cell lymphoma, specifically Sézary syndrome. Innate Pharma also appointed Markus Jensen as Chief Medical Officer.

Aug 10, 20269 sources

Sobi and Innate Pharma Form $580M Partnership to Advance Lacutamab to Phase 3 for Rare Skin Cancer

Spatial transcriptomics reveals molecular programs linked to heart-transplant rejection

Researchers at Vanderbilt Health have published findings in Nature Cardiovascular Research showing that spatial transcriptomics of cardiac biopsies reveals significant cellular and molecular variation in transplant rejection that is not captured by conventional biopsy grading, potentially enabling precision medicine approaches to organ rejection treatment.

Aug 10, 20264 sourcesSpatial transcriptomics Precision medicine

Spatial transcriptomics reveals molecular programs linked to heart-transplant rejection

Tenax’s TNX-103 fails primary endpoint in Phase 3 PH-HFpEF trial

Tenax Therapeutics' stock collapsed on August 10, 2026, after the company announced its Phase 3 LEVEL trial of TNX-103 (oral levosimendan) failed to significantly improve walking distance in patients with pulmonary hypertension associated with heart failure compared to placebo, missing its primary endpoint.

Aug 10, 202616 sources

Tenax’s TNX-103 fails primary endpoint in Phase 3 PH-HFpEF trial

UK becomes first European country to approve Eli Lilly's once-daily weight loss pill Foundayo

The UK's Medicines and Healthcare products Regulatory Agency has authorized orforglipron (brand name Foundayo), a once-daily oral medication from Eli Lilly for treating obesity and type 2 diabetes, making the UK the first country in Europe to approve the drug.

Aug 10, 20266 sourcesObesity treatment Weight loss medications Healthcare Policy

UK becomes first European country to approve Eli Lilly's once-daily weight loss pill Foundayo

AbCellera's experimental menopause drug shows significant reduction in hot flashes in Phase 2 trial, shares surge 40%

AbCellera Biologics reported that its non-hormonal menopause treatment ABCL-635 significantly reduced the frequency and severity of hot flashes in a 92-person Phase 2 trial, with the drug meeting both primary endpoints after four weeks. The results sent the company's shares surging nearly 40% in early trading.

Aug 10, 20269 sourcesWomen’s health Biotechnology

AbCellera's experimental menopause drug shows significant reduction in hot flashes in Phase 2 trial, shares surge 40%

Silence Therapeutics reports positive Phase 2 trial results for divesiran in rare blood cancer

Silence Therapeutics announced that its Phase 2 SANRECO trial of divesiran met its primary endpoint in patients with polycythemia vera, a rare blood cancer, with data showing the treatment stabilized red blood cell levels and reduced phlebotomies to 0.2 per patient over 36 weeks. The company's stock rallied significantly on the news.

Aug 10, 20269 sourcesClinical trials Biotechnology Rare diseases

Silence Therapeutics reports positive Phase 2 trial results for divesiran in rare blood cancer

Taylor Farms recalls salsa and guacamole products across 26 states over salmonella contamination risk

California-based produce supplier Taylor Farms has voluntarily recalled prepared foods containing jalapeños, including salsa and guacamole, sold at retailers like Walmart and Whole Foods across 26 states after supplier Coast Citrus Distributors recalled fresh peppers due to potential salmonella contamination. The recall comes weeks after the company was linked to a separate cyclosporiasis outbreak.

Aug 9, 20269 sourcesFood regulation Public health

Taylor Farms recalls salsa and guacamole products across 26 states over salmonella contamination risk

Hunter Biden says Joe Biden's cancer has spread and is 'very painful'

Former President Joe Biden's son Hunter Biden revealed that his father's cancer has progressed further and is causing significant pain, marking a concerning development in the former president's health condition.

Aug 8, 20264 sourcesJoe Biden Cancers Public health Presidential health

Hunter Biden says Joe Biden's cancer has spread and is 'very painful'

Canada's measles rate per capita surpasses U.S. as North American outbreak expands

WHO data reveals Canada has approximately half the measles cases of the United States despite having only one-tenth the population, indicating a significantly higher per capita infection rate. The U.S. has reported 2,465 cases for the year, with 94 new cases added in a single week, mostly in Pennsylvania, while Manitoba has seen cases drop to just two in July.

Aug 8, 20266 sourcesMeasles outbreak Public healthcare Vaccination rates

Canada's measles rate per capita surpasses U.S. as North American outbreak expands

RFK Jr. criticizes U.S. Covid response at CDC shooting memorial

Health and Human Services Secretary Robert F. Kennedy Jr. told CDC staff that the U.S. would have done better in the Covid outbreak by listening to alternative voices, speaking at a memorial for last year's shooting at the agency.

Aug 7, 20262 sourcesTrump administration Centers for Disease Control and Prevention Public healthcare

RFK Jr. criticizes U.S. Covid response at CDC shooting memorial

Scholar Rock Removes Novo Nordisk Indiana Facility from FDA Application for Rare Muscle Weakness Drug

Scholar Rock announced it will remove Novo Nordisk's (formerly Catalent's) Indiana manufacturing facility from its FDA biologics license application for a treatment targeting a rare neuromuscular disease. The regulatory filing adjustment comes as the company seeks approval for its muscle weakness therapy.

Aug 7, 20265 sources

Scholar Rock Removes Novo Nordisk Indiana Facility from FDA Application for Rare Muscle Weakness Drug

Two-thirds of NHS mental health providers in England plan service cuts and job losses

More than two-thirds of NHS mental health providers in England are planning to cut services, with half expected to eliminate jobs, threatening to increase wait times for millions of adults and children seeking mental health care.

Aug 7, 20261 sourcePublic healthcare Mental health

Two-thirds of NHS mental health providers in England plan service cuts and job losses

BlossomHill Therapeutics raises $150 million in upsized oncology IPO

Oncology-focused biotech firm BlossomHill Therapeutics raised $150 million in an upsized U.S. initial public offering, though shares fell 1.6% in their trading debut.

Aug 7, 20262 sources

BlossomHill Therapeutics raises $150 million in upsized oncology IPO

Study finds next-generation AI medical models still perpetuate racial and gender stereotypes

Flinders University researchers evaluated two advanced reasoning large language models—o3-mini and DeepSeek-R1—and discovered they continue to reproduce racial and gender stereotypes when describing fictional patients with common medical conditions, despite being newer generation AI systems.

Aug 7, 20261 sourceReasoning models AI bias & fairness AI ethics AI safety & social impact AI research & benchmarks

Study finds next-generation AI medical models still perpetuate racial and gender stereotypes

New Pulse Oximeter Technology Adapts to Different Skin Tones

Researchers have developed an improved pulse oximeter that adjusts for variations in skin color, addressing longstanding accuracy concerns with traditional devices that have been used for decades to measure blood oxygen levels.

Aug 7, 20261 sourceBiomedical engineering AI bias & fairness

New Pulse Oximeter Technology Adapts to Different Skin Tones

Multistate salmonella outbreak linked to fresh jalapeño peppers under investigation

U.S. health authorities are investigating a multistate outbreak of salmonella javiana infections linked to fresh jalapeño peppers. The investigation is being conducted jointly by federal health agencies.

Aug 7, 20262 sources

Multistate salmonella outbreak linked to fresh jalapeño peppers under investigation

Wildfires Become Leading Source of Unhealthy Air Pollution for Pregnant Women in U.S., Study Finds

A new study published in Frontiers in Environmental Health reveals that while overall prenatal exposure to fine particulate matter (PM2.5) decreased between 2003 and 2019, wildfire smoke's contribution to prenatal PM2.5 exposure more than doubled during this period, making it the dominant source of unhealthy air pollution for pregnant women in the United States.

Aug 7, 20263 sourcesPublic health Climate change health impacts

Wildfires Become Leading Source of Unhealthy Air Pollution for Pregnant Women in U.S., Study Finds

FDA Schedules Advisory Committee Meeting for Grail's Galleri Multi-Cancer Screening Test

The U.S. Food and Drug Administration will convene its Molecular and Clinical Genetics Panel on September 23, 2026, to review Grail's premarket approval application for Galleri, a multi-cancer early detection test. The advisory committee meeting represents a critical regulatory milestone for the company, which anticipates a potential approval decision in early 2027.

Aug 7, 20269 sourcesFDA regulatory process Early cancer detection

FDA Schedules Advisory Committee Meeting for Grail's Galleri Multi-Cancer Screening Test

Aug 7, 202616 sourcesEarly cancer detection Preventive medicine Preventive healthcare FDA regulatory process

New Mexico Court Orders Meta to Pay $567 Million in Youth Mental Health Case

A New Mexico judge ordered Meta to pay $567 million to address harms to young people from Facebook and Instagram in the second phase of a landmark trial. The ruling brings Meta's total penalties in the case to over $1 billion and requires sweeping protections for teen users.

Aug 6, 20266 sourcesSocial media regulation AI safety & social impact Youth mental health AI regulation & lawsuits

New Mexico Court Orders Meta to Pay $567 Million in Youth Mental Health Case

Drug-Resistant Fungus Candida auris Spreads to 27 US States, Scientists Discover It Hides in Hair Follicles

Scientists have discovered how Candida auris, a deadly drug-resistant fungus that has infected over 3,000 patients across 27 US states this year, survives on human skin by hiding in hair follicles and hijacking the body's immune response. The pathogen, which the CDC considers an urgent antimicrobial threat, can colonize skin asymptomatically for months before becoming deadly if it enters the bloodstream through wounds or medical devices.

Aug 6, 20269 sourcesPublic healthcare Antimicrobial resistance

Drug-Resistant Fungus Candida auris Spreads to 27 US States, Scientists Discover It Hides in Hair Follicles

CDC Reports Sharp Rise in Emergency Room Visits for Cannabis Hyperemesis Syndrome Among Frequent Marijuana Users

A new CDC report reveals nearly 200,000 emergency room visits in the past year for cannabis hyperemesis syndrome (CHS), a condition causing severe nausea and vomiting in frequent marijuana users. The increase may reflect both rising cases and improved diagnostic coding.

Aug 6, 20266 sourcesPublic healthcare Addiction & recovery Emergency medicine

CDC Reports Sharp Rise in Emergency Room Visits for Cannabis Hyperemesis Syndrome Among Frequent Marijuana Users

Sweetgreen cuts annual outlook as cyclospora outbreak reduces demand for fresh produce

Sweetgreen slashed its annual same-store-sales projections as consumers grew wary of fresh produce amid a widespread cyclospora outbreak, with shares dropping 15% in premarket trading.

Aug 6, 20262 sourcesRestaurant industry Cyclosporiasis outbreak Consumer behavior Public healthcare

Sweetgreen cuts annual outlook as cyclospora outbreak reduces demand for fresh produce

Study Links Three Midlife Health Factors to 13 Additional Dementia-Free Years

New research published in Neurology Open Access finds that maintaining normal blood pressure, avoiding type 2 diabetes, and not smoking between ages 45-68 is associated with nearly 13 more years of dementia-free life after age 55 compared to those with all three risk factors.

Aug 6, 20269 sourcesLifestyle optimization Preventive longevity physicians Cardiovascular aging experts Biomarkers & bloodwork testing Age related cognitive decline Alzheimer’s & dementia

Study Links Three Midlife Health Factors to 13 Additional Dementia-Free Years

Michigan lifts lettuce warning as cyclospora cases decline

Michigan health officials cleared shoppers to resume normal lettuce consumption after cyclospora parasite infections linked to tainted lettuce began declining. The outbreak had prompted widespread warnings and consumer anxiety about salad greens.

Aug 6, 20263 sourcesCyclosporiasis outbreak Public health

Michigan lifts lettuce warning as cyclospora cases decline

FDA approves Replimune's melanoma drug after two prior rejections

The FDA granted accelerated approval to Replimune's TUDRIQEVTM (vusolimogene oderparepvec-wtpg) for melanoma treatment, reversing two earlier rejections following support from an advisory panel. The approval marks a significant turnaround for the biotech company after a tumultuous regulatory process.

Aug 6, 20263 sourcesCancer treatment Cancer treatment breakthroughs

FDA approves Replimune's melanoma drug after two prior rejections

Amazon Pharmacy begins offering GLP-1 weight loss drugs to Medicare patients

Amazon announced that Medicare Part D patients can now access certain GLP-1 weight-loss medications including oral and injectable versions of Novo Nordisk's drugs through Amazon Pharmacy.

Aug 6, 20262 sourcesWeight management Novo Nordisk US health policy & drug pricing Public healthcare

Amazon Pharmacy begins offering GLP-1 weight loss drugs to Medicare patients

Senate committee votes to hold Anthony Fauci in contempt of Congress

The Senate Homeland Security and Governmental Affairs Committee voted along party lines to hold Anthony Fauci in contempt after he invoked the Fifth Amendment and declined to answer questions about his role in the Covid-19 pandemic response.

Aug 6, 20262 sourcesUS health policy & drug pricing US Congress Public healthcare Congressional oversight

Senate committee votes to hold Anthony Fauci in contempt of Congress

Scientists Discover Immune Cell Migration from Blood to Brain Beginning at Age 50

Researchers have overturned long-held scientific understanding by discovering that aging human brains undergo a massive influx of peripheral blood-derived immune cells starting around age 50, replacing resident microglia with more inflammatory cells. This shift may help explain how normal aging sets the stage for Alzheimer's disease and dementia.

Aug 6, 20265 sourcesAlzheimer’s & dementia Brain longevity Brain health & dementia researchers Neuroinflammation Aging biology experts Age related cognitive decline

Scientists Discover Immune Cell Migration from Blood to Brain Beginning at Age 50

Israeli rights group warns West Bank healthcare system nearing collapse amid funding crisis

Physicians for Human Rights Israel released a report warning that the Palestinian public healthcare system in the occupied West Bank is on the brink of collapse, citing Israel's withholding of tax revenues from the Palestinian Authority as pushing hospitals and clinics to crisis point.

Aug 6, 20265 sourcesIsraeli domestic politics Wars & conflicts Palestinian governance Humanitarian crises Public healthcare

Israeli rights group warns West Bank healthcare system nearing collapse amid funding crisis

Intellia Therapeutics Reports Positive Phase 3 Results for HAE Treatment, Plans 2027 U.S. Launch

Intellia Therapeutics announced second quarter 2026 financial results alongside positive Phase 3 clinical data for lonvo-z in hereditary angioedema (HAE), with FDA biologics license application acceptance anticipated in late 2026 and U.S. commercial launch planned for first half of 2027.

Aug 6, 20262 sourcesRare diseases Gene therapy

Intellia Therapeutics Reports Positive Phase 3 Results for HAE Treatment, Plans 2027 U.S. Launch

Tarsus Pharmaceuticals to Acquire Alkeus for Up to $800M, Gaining Late-Stage Stargardt Disease Drug

Tarsus Pharmaceuticals agreed to acquire privately-held Alkeus Pharmaceuticals for $450 million upfront and up to $800 million total, gaining gildeuretinol (ALK-001), a Phase 3 oral therapy for Stargardt disease. The rare genetic eye condition affects over 36,000 people in the U.S. and currently has no FDA-approved treatment, with pivotal trial data expected in late 2029.

Aug 6, 20265 sourcesClinical trials

Tarsus Pharmaceuticals to Acquire Alkeus for Up to $800M, Gaining Late-Stage Stargardt Disease Drug

Child dies in Chinese gene-editing trial for Duchenne muscular dystrophy, raising safety and transparency concerns

A child has died during a gene-editing clinical trial in China conducted by a Chinese startup for Duchenne muscular dystrophy treatment, reigniting debate about regulatory oversight and transparency in the country's biotech sector.

Aug 6, 20262 sources

Child dies in Chinese gene-editing trial for Duchenne muscular dystrophy, raising safety and transparency concerns

KKR Acquires Medicover India's 24-Hospital Network for $1.3 Billion

Global investment firm KKR has signed a definitive agreement to acquire Medicover India, the Indian hospital business of Stockholm-based Medicover, in a deal valued at approximately $1.3 billion (₹10,000-14,250 crore). The acquisition marks KKR's largest healthcare deal in India and includes a 24-hospital network, with plans for additional investment of ₹3,000-4,000 crore for expansion.

Aug 6, 20267 sourcesCross-border healthcare

KKR Acquires Medicover India's 24-Hospital Network for $1.3 Billion

FDA approves Moderna's mFlusiva, first mRNA-based flu vaccine in the United States

The Food and Drug Administration approved Moderna's mFlusiva on Wednesday, marking the first mRNA-based influenza vaccine authorized in the U.S. The vaccine is approved for adults aged 50 and older, representing a significant expansion of mRNA technology beyond COVID-19 vaccines.

Aug 6, 20266 sourcesFDA drug approval Public healthcare MRNA vaccine technology Technology Innovation

FDA approves Moderna's mFlusiva, first mRNA-based flu vaccine in the United States

Over 200 Deaths Linked to Weight Loss Drugs in UK, Regulatory Data Shows

The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has reported that more than 200 deaths have been linked to weight loss medications including Wegovy and Mounjaro, with the majority associated with tirzepatide. The data also shows approximately 18,000 adverse reactions have been reported.

Aug 6, 20263 sourcesGLP-1 medications Public healthcare

Over 200 Deaths Linked to Weight Loss Drugs in UK, Regulatory Data Shows

UK's First Publicly Funded Trial Shows Psilocybin Significantly Improves Treatment-Resistant Depression

A randomized controlled trial conducted through the NHS in England found that a single dose of psilocybin, the active compound in magic mushrooms, produced significant improvements in depression symptoms among 60 adults with treatment-resistant major depressive disorder compared to placebo, with good tolerability.

Aug 6, 20264 sourcesPsilocybin Psychedelic policy & regulation Public healthcare Psychedelic clinical research & trials Mental health Depression

UK's First Publicly Funded Trial Shows Psilocybin Significantly Improves Treatment-Resistant Depression

DR Congo quarantines river boat with over 200 passengers near Kinshasa after suspected Ebola death

Congolese health authorities intercepted the Yingfeng 2 river boat on the Congo River near Kinshasa and placed hundreds of passengers under quarantine after a passenger who had disembarked earlier died from suspected Ebola. Screening is underway for all passengers and crew.

Aug 6, 20267 sourcesEbola outbreak Disease surveillance Public health emergencies

DR Congo quarantines river boat with over 200 passengers near Kinshasa after suspected Ebola death

UK Scientists Successfully Trial First 'Fridge-Free' Vaccines in Patients

British researchers have conducted the first successful clinical trials of vaccines that do not require refrigeration, a breakthrough that could address the problem of half of all vaccines being discarded due to cold chain failures.

Aug 5, 20263 sourcesMedical innovation Clinical trials Public healthcare Vaccine development Global health security

UK Scientists Successfully Trial First 'Fridge-Free' Vaccines in Patients

Study finds diabetes drug tirzepatide reduces heart attack and stroke risk in high-risk patients

New research published in The BMJ shows that tirzepatide (Mounjaro), a GLP-1 receptor agonist, reduces the risk of major cardiovascular events by 33% in type 2 diabetes patients with existing heart disease. A separate study also found that consistent medication adherence among diabetes patients reduces heart disease risk by 27%.

Aug 5, 20269 sourcesCardiovascular health.GLP-1 medications Medication adherence

Study finds diabetes drug tirzepatide reduces heart attack and stroke risk in high-risk patients

Mounjaro Found to Reduce Heart Attack Risk by 33% in Type 2 Diabetes Patients with Heart Disease

A new study shows that tirzepatide (Mounjaro), a GLP-1 receptor agonist drug, reduces heart attack risk by 33% when added to standard care for patients with both type 2 diabetes and existing heart disease. The findings come as worldwide sales of the drug doubled to £13.8 billion in the first half of 2026.

Aug 5, 20265 sourcesGLP-1 medications GLP-1 receptor agonists Cardiovascular health.

Mounjaro Found to Reduce Heart Attack Risk by 33% in Type 2 Diabetes Patients with Heart Disease

Trump Administration Shuts Down Kentucky Organ Donation Group Over Allegations of Attempting Organ Retrieval from Living Patients

The U.S. Department of Health and Human Services announced it will decertify Network for Hope, a Kentucky-based organ procurement organization, following allegations that staff continued with organ retrieval procedures despite patients showing signs of life, including a case where a patient was thrashing, crying, and shaking his head.

Aug 5, 20267 sourcesUS healthcare regulation Patient safety Trump administration Public healthcare Medical ethics

Trump Administration Shuts Down Kentucky Organ Donation Group Over Allegations of Attempting Organ Retrieval from Living Patients

UK government announces over 100 walk-in mental health centres to open in libraries, banks and high street locations across England

The UK government has unveiled plans to open more than 100 walk-in mental health hubs in accessible community locations including libraries, banks and high street premises across England, alongside dedicated mental health emergency departments in hospitals. Health Secretary Andy Burnham described the initiative as the 'biggest redesign of mental health services in a generation' aimed at providing earlier intervention and preventing people from reaching crisis point.

Aug 5, 20268 sourcesTherapy & counseling Mental health Public healthcare

UK government announces over 100 walk-in mental health centres to open in libraries, banks and high street locations across England

FDA approves Takeda's Orzeyful, first orexin agonist drug for narcolepsy type 1

The FDA has approved Takeda's Orzeyful (orexin agonist) for treating narcolepsy type 1 in adults, marking the first approval in a new class of sleep medicines that addresses the full range of narcolepsy symptoms. The approval is expected to reshape the treatment paradigm and launch a closely watched commercial drug race.

Aug 5, 20265 sourcesDrug development Sleep disorders Sleep & circadian rhythm

FDA approves Takeda's Orzeyful, first orexin agonist drug for narcolepsy type 1

Join the Health community

All of the news data is pulled from the Health space in Geo

235 members

18 editors

View space

Featured Timelines